899 people got expired vaccine doses at Times Square site
In this April 12, 2021 file photo, actor Lin-Manuel Miranda, center, bumps elbows with a worker at the ATC Vaccination Services site in New York's Times Square. He's accompanied by New York Mayor Bill de Blasio, second from right, and ATC Alert founder & CEO Jordan Savitsky, right. Nearly 900 people received expired Pfizer COVID-19 vaccine doses at the vaccination site in Times Square this month, health officials said Tuesday, June 15, 2021. Credit: AP Photo/Richard Drew, Pool, File
Nearly 900 people received expired COVID-19 vaccine doses at a vaccination site in Times Square this month, health officials said Tuesday.
The 899 people who received doses of the Pfizer vaccine at the former NFL Experience building in Times Square between June 5 and June 10 should schedule another Pfizer shot as soon as possible, the New York City Health Department said.
ATC Vaccination Services, the company that administered the shots under contract to the city, said in a statement, "We apologize for the inconvenience to those receiving the vaccine batch in question and want people first and foremost to know that we have been advised that there is no danger from the vaccine they received."
Health Department spokesperson Patrick Gallahue said those who got the expired doses "have received e-mails, phone calls, and are also being sent letters to make sure they are aware of this situation."
In this April 12, 2021 file photo, people are interviewed before receiving Pfizer COVID-19 vaccine at the ATC Vaccination Services site in New York's Times Square. Nearly 900 people received expired Pfizer COVID-19 vaccine doses at the vaccination site in Times Square this month, health officials said Tuesday, June 15, 2021. Credit: AP Photo/Richard Drew, Pool, File
Citation:
899 people got expired vaccine doses at Times Square site (2021, June 15)
retrieved 23 April 2024
from https://medicalxpress.com/news/2021-06-people-expired-vaccine-doses-square.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
